Premise Malaria COVID-19 Health Services Disruption Survey 2021
Survey:
Cross-sectional - Individual
Medical tests
Dataset Records for Medical tests
Displaying 1 - 50 of 721
Premise Malaria COVID-19 Health Services Disruption Survey 2021
Netherlands - Coronavirus antibodies in an average of 18.6% of the donors
Antistoffen coronavirus bij gemiddeld 18,6% van de donors
United States COVID Tracking Project 2021
The COVID Tracking Project at The Atlantic
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 5 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
United States - COVID-19 Diagnostic Laboratory Testing (PCR Testing) Time Series
Epi surveillance:
Health facility - Subnationally representative
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
Canada - British Columbia COVID-19 Situation Report Weekly Bulletin
British Columbia (BC) COVID-19 Situation Report
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: Jun 17, 2021
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
Nepal National Sero-Prevalence Survey for COVID-19 October 2020
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: Jun 29, 2021
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020
GHDx Entry last modified on: Jul 1, 2021
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19
Survey:
Cross-sectional - Epi surveillance - Urban only
20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest
Survey:
Cross-sectional - Epi surveillance - Urban only
Mexico - Yucatán Under-5 Endline Household Survey 2020
Survey:
Cross-sectional - Household - Individual - Interview
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares -
29.1% people in Delhi developed antibodies against COVID-19, finds latest sero-survey
GHDx Entry last modified on: Jul 15, 2021
Press Briefing: Sero Survey Delhi
Survey:
Cross-sectional - Urban only
Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey
Survey:
Urban only
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares -
About 10 million people have been infected with the Corona virus in Afghanistan
حدود ده ملیون تن در افغانستان به ویروس کرونا مبتلا شده اند
Premise Malaria COVID-19 Health Services Disruption Survey 2020
Survey:
Cross-sectional - Individual
Serum-epidemiological Survey of SARS-CoV-2, City of Pemba (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Pemba (InCOVID 2020) - Resultados Preliminares -
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
Israel - Press Releases Results of the National Serological Survey for Novel Coronavirus
GHDx Entry last modified on: Jul 2, 2021
Epidemiological and Serological Surveillance of COVID-19 in Pune City, Technical Report, August 16, 2020
Technical Report (dt August 16, 2020): Epidemiological and Serological Surveillance of COVID-19 in Pune City
Survey:
Epi surveillance
Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana. Preprint
GHDx Entry last modified on: Jun 17, 2021
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions. Preprint
GHDx Entry last modified on: Jun 17, 2021
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
GHDx Entry last modified on: Jun 17, 2021
Oman COVID-19 National Serological Survey Phase 1 2020
National Sero-Survey of COVID-19 Infection First Phase
Survey:
Cross-sectional - Epi surveillance
Health Minister Fahrettin Koca announced the results of Turkey's antibody test
Sağlık Bakanı Fahrettin Koca Türkiye’nin antikor testi sonuçlarını açıkladı
Rapid increase of SARS-CoV-2 seroprevalence during the 2020 pandemic year in the population of the city of Tirana, Albania. Preprint
GHDx Entry last modified on: Jun 18, 2021
Presence of antibodies against SARS-CoV-2 in the district area Rinkeby-Kista, Stockholm, 22–24 June 2020
Förekomsten av antikroppar mot SARS-CoV-2 i stadsdelsområdet Rinkeby-Kista, Stockholm, 22–24 juni 2020
Survey:
Community - Cross-sectional - Exam - Urban only
Jersey SARS-CoV-2: Prevalence of antibodies in Jersey 2020
Survey:
Epi surveillance
[Martinez Benazet thanks institutions, volunteers and the population who have participated in the national antibody study]
Martinez Benazet agraeix a institucions, voluntaris i a la població que ha participat en l’estudi nacional d’anticossos
Survey:
Epi surveillance
Suriname COVID-19 Situation Report 2020
GHDx Entry last modified on: Sep 3, 2021
Positive Rate of Serology and RT-PCR for COVID-19 between Community Residents and Healthcare Workers in Wuhan, China
GHDx Entry last modified on: Jun 17, 2021
Popova declared immunity to coronavirus in 14% of those tested
Попова заявила об иммунитете к коронавирусу у 14% протестированных
In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2
Survey:
Longitudinal
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
GHDx Entry last modified on: Jun 17, 2021
Portugal National Serological Survey COVID-19 Preliminary results 2020
Relatório de Apresentação dos Resultados Preliminares do Primeiro Inquérito Serológico Nacional COVID-19
Canada - Quebec COVID-19 First Wave Blood Donor Seroprevalence Study 2020
Étude De Séroprévalence Des Anti-Sras-Cov-2 Chez Les Donneurs De Sang D’héma-Québec, Vers La Fin De La Première Vague De Covid-19
Survey:
Epi surveillance
United Kingdom Coronavirus (COVID-19) Data Dashboard
GHDx Entry last modified on: May 5, 2021
Seroprevalence of COVID-19 virus infection in Guilan province, Iran. Preprint
GHDx Entry last modified on: Mar 25, 2021
Subscribe